THÔNG TIN TÀI LIỆU
Thông tin cơ bản
Định dạng | |
---|---|
Số trang | 50 |
Dung lượng | 11,24 MB |
Nội dung
Ngày đăng: 22/04/2017, 17:02
Nguồn tham khảo
Tài liệu tham khảo | Loại | Chi tiết |
---|---|---|
11. Rudnick.M.R et al: Pathogenesis, clinical features, and dianosis of radiocontrast media-induced acute renal failure. Uptodate 15.2. 2007 12. Davidson C, Hlatky M, Morris K. Cardiovascular and renal toxicity ofa nonionic radiocontrast agent after cardiac catheterization. Ann Intern Med 1989; 110: 119-20 | Khác | |
14. Frame.J.N et al: heparin-induced thrombocytopenia and PCI.Cardiology special edition 2004, vol 10: 24-30 | Khác | |
15. Hamdalla.H, Steinhubl. S.R: role of platelet inhibitor agents in percutaneous coronary intervention. In Topol.E.J: textbook of interventional cardiology. 5 th 2008;p:147-164 | Khác | |
16. Kern.M.J Medical therapy after PCI. In Kern.M.J: The interventional cardiac catheterization hanbook. 2th 2004. p: 67-69 | Khác | |
17. Costa.M.A, Simon.D.I: Restenosis. In Topol.E.J: textbook of interventional cardiology. 5 th 2008;p:567-587 | Khác | |
18. Papaioannou.G.I et al: Role of stress testing after coronary revascularization. Uptodate 15.2. 2007 | Khác | |
19. Gerber.T.C, Manning.W.J: noninvasive coronary arteriography with cardiac computer tomography and cardiovascular manegtic resonance.Uptodate 15.2, 2007 | Khác | |
20. Roffi M, Wenaweser P, Meier B et al. Early exercise after coronary stenting is safe. J Am Coll Cardiol 2003; 42: 1569-73 | Khác | |
22. Chew.D.P: anticoagulation in percutaneous coronary. In Topol.E.J:textbook of interventional cardiology. 5 th 2008;p:164- 182 | Khác | |
23. Rubboli.A, Verheugt.F.W.A: antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting. Int J of cardio 2007: 1-5 | Khác | |
24. Cutlip.D, Levin.T : antithrombotic therapy for intracoronary stent implantation: recommendations. Uptodate 15.2, 2007 | Khác | |
25. Bertrand .M.E: when and how to discontinue antiplatelet therapy. Eur Heart J. 2008 ( suppl A) : A 35- A 41 | Khác | |
26. Brilakis.E.S et al: perioperative management of patients with coronary stent. JACC 2007, 49: 2145-2150 | Khác | |
27. Serruys PW. Arterial Revascularization Therapies Study Part II:Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. American College of Cardiology 2005 Annual Scientific Session | Khác | |
28. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U S Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334:1349- 55 | Khác | |
29. CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 1999; 353: 9-13 | Khác | |
30. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-7 | Khác | |
32. Kuck KH, Cappato R, Siebels J et al. Randomised comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-54 | Khác | |
33. Brady GH, Lee KL, Mark DB et al. SCD-HeFT Investigators.Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37 | Khác | |
34. Yusuf S, Sleight P, Pogue J et al. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-53 | Khác |
TỪ KHÓA LIÊN QUAN
TÀI LIỆU CÙNG NGƯỜI DÙNG
TÀI LIỆU LIÊN QUAN